Do age and comorbidity impact treatment allocation and outcomes in limited stage small-cell lung cancer? a community-based population analysis

scientific article

Do age and comorbidity impact treatment allocation and outcomes in limited stage small-cell lung cancer? a community-based population analysis is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1016/S0360-3016(02)04576-5
P698PubMed publication ID12654444

P2093author name stringPauline T Truong
Jan Lim
Mary Lesperance
Howard Joe
Heidi Martins
Mary V MacNeil
Adam Webber
Joanna J S Ludbrook
P2860cites workProphylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysisQ24800321
A new method of classifying prognostic comorbidity in longitudinal studies: development and validationQ29547376
Toxicity and response criteria of the Eastern Cooperative Oncology GroupQ29619399
Carboplatin, etoposide, and accelerated hyperfractionated radiotherapy for elderly patients with limited small cell lung carcinoma: a phase II studyQ33501796
Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative GroupQ33870498
Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data baseQ33934669
Treatment and outcomes for elderly patients with small cell lung cancerQ34067406
Influence of age and comorbidities on the chemotherapeutic management of lung cancerQ34384478
Retrospective review of chemotherapy for small cell lung cancer in the elderly: does the end justify the means?Q36461621
Treatment of small cell lung cancer in the elderlyQ40798998
A meta-analysis of thoracic radiotherapy for small-cell lung cancerQ41086687
Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysisQ45371243
Similar outcome of elderly patients in intergroup trial 0096: Cisplatin, etoposide, and thoracic radiotherapy administered once or twice daily in limited stage small cell lung carcinomaQ46242749
Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials GroupQ48341719
Prognostic factors in small-cell carcinoma of the lung: an analysis of 1,521 patients.Q52867345
Five-day oral etoposide treatment for advanced small-cell lung cancer: randomized comparison with intravenous chemotherapy.Q53598860
Prophylactic Cranial Irradiation for Patients With Small-Cell Lung Cancer in Complete RemissionQ57665429
Influence of age on the treatment of limited-stage small-cell lung cancerQ59647379
Treatment of small cell lung carcinoma in the elderlyQ71102123
Underrepresentation of patients 65 years of age or older in cancer-treatment trialsQ73311140
Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: results of a multicentre randomised trial. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) and the EuropeanQ74202008
Abbreviated treatment for elderly, infirm, or noncompliant patients with limited-stage small-cell lung cancerQ77435853
Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposideQ77912158
Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancerQ77957625
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectcomorbidityQ1414874
P304page(s)1321-1330
P577publication date2003-04-01
P1433published inInternational Journal of Radiation Oncology Biology PhysicsQ2296252
P1476titleDo age and comorbidity impact treatment allocation and outcomes in limited stage small-cell lung cancer? a community-based population analysis
P478volume55

Reverse relations

cites work (P2860)
Q36614935A new simplified comorbidity score as a prognostic factor in non-small-cell lung cancer patients: description and comparison with the Charlson's index
Q37392175Assessment of health status in elderly patients with cancer
Q36552519Barriers to accessing radiation therapy in Canada: a systematic review.
Q33798652Better cancer specific survival in young small cell lung cancer patients especially with AJCC stage III
Q47362756Can weight loss at presentation predict patient outcome in lung cancer?
Q39753118Characteristics of patients and predictors of in-hospital mortality after hospitalization for head and neck cancers
Q46601897Chemoradiotherapy for locally advanced pancreatic carcinoma in elderly patients
Q43529176Chemotherapy in elderly small-cell lung cancer patients: yes we can, but should we do it?
Q47679773Comorbidity Profiles of Patients with Lung Cancer: A New Approach to Risk Stratification?
Q40612067Comorbidity and outcomes of concurrent chemo- and radiotherapy in limited disease small cell lung cancer
Q58574211Compliance and outcome of elderly patients treated in the Concurrent ONce daily VErsus twice-daily RadioTherapy (CONVERT) trial
Q41380574Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial
Q36439424Cost-effectiveness of chemotherapy combined with thoracic radiotherapy versus chemotherapy alone for limited stage small cell lung cancer: A population-based propensity-score matched analysis
Q38608627Current challenges of lung cancer care in an aging population
Q34266302Decreased survival among lung cancer patients with co-morbid tuberculosis and diabetes
Q73166784Do "elderly fit" patients have less comorbidity?
Q44509853Effect of prophylactic cranial irradiation on survival in elderly patients with limited-stage small cell lung cancer
Q39814474Health behaviors and demographic factors of chronic health conditions among elderly veteran men.
Q35208186How do patient and hospital features influence outcomes in small-cell lung cancer in England?
Q40049755Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients ≥65 years old.
Q36967155Modern management of small-cell lung cancer
Q38451808No improvement in lung cancer care: the management of lung cancer in 1996 and 2002 in New South Wales.
Q50050610Prognostic factors and survival of patients with small cell lung cancer in a northeastern Chinese population
Q33625372Prognostic factors for limited-stage small cell lung cancer: a study of 284 patients.
Q38002472Prophylactic cranial irradiation for small-cell lung cancer: how, when and for whom?
Q57495396Prophylactic cranial irradiation in small-cell lung cancer: update on patient selection, efficacy and outcomes
Q37614574Radiochemotherapy in the elderly with lung cancer.
Q35107298Small-cell lung cancer in England: trends in survival and chemotherapy using the National Lung Cancer Audit
Q51656955Survival and prognostic factors in small cell lung cancer.
Q40508047The Younger Patients Have More Better Prognosis in Limited Disease Small Cell Lung Cancer
Q83352619The influence of age and comorbidity on receiving radiotherapy as part of primary treatment for cancer in South Netherlands, 1995 to 2002
Q33994360The role of patient, tumour and system factors in socioeconomic inequalities in lung cancer treatment: population-based study
Q30830775The role of receipt and timeliness of treatment in socioeconomic inequalities in lung cancer survival: population-based, data-linkage study
Q36715266Tolerance to chemotherapy in elderly patients with cancer
Q37723646Treatment of small cell lung cancer in academic and community settings: factors associated with receiving standard therapy and survival
Q37677010Treatment of small-cell lung cancer in elderly patients
Q38068403Uptake and tolerance of chemotherapy in elderly patients with small cell lung cancer and impact on survival
Q37783975Utilization of prophylactic cranial irradiation in patients with limited stage small cell lung carcinoma.
Q83308902Whole-body metabolic tumour volume of 18F-FDG PET/CT improves the prediction of prognosis in small cell lung cancer

Search more.